Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- CAR T-cell therapy may be a ‘miracle,’ but it is too soon to say ‘cure’ Rob Volansky
-
- CAR T cells one year later: What have we learned? Leonard H. Calabrese, DO
- ACR: Prior authorization, fee schedule reform must be Congress’ ‘top priority’ Justin Cooper
- ‘Don’t miss this’: Rare types of Ehlers-Danlos syndrome can be life-threatening Justin Cooper
- FDA approves Rinvoq for JIA, psoriatic arthritis in children aged 2 years and older
- Mark Cuban’s Cost Plus Drug Company ‘flying under the radar’ after 2 years Rob Volansky
- New EULAR trial center network, databases ‘crucial’ to advancing RMD care quality Justin Cooper
- Nurse-led gout care doubles rate of patients achieving target urate, improves continuance Justin Cooper
- One-quarter of patients with gout receive colchicine despite potential interactions Justin Cooper
-
- Patients with arthritis at higher risk for poor nutrition regardless of function Justin Cooper
- Push to ‘repair the mitochondria’ may revolutionize rheumatoid arthritis treatment Rob Volansky
- Simplified lupus infection prediction score more accurate, feasible than previous version Justin Cooper
- Targeted psoriatic arthritis therapies demonstrate low risk for serious infection Justin Cooper
- TNF inhibitor efficacy in axial spondyloarthritis varies greatly by sex via BASDAI score Justin Cooper
- Trustworthiness of chronic pain clinical practice guidelines ‘should not be assumed’ Justin Cooper
- Uplizna reduces IgG4 related disease flare risk by 87% in MITIGATE trial
- ‘Very important’: Belimumab decreases lupus flare vs. placebo in early, established disease Justin Cooper
-
- VIDEO: Medicare physician fee schedule ‘on an untenable track’ Justin Cooper